Category Archives: Articles

The first Annual Israeli Meeting of translational research on stem cells, cell therapy and regenerative medicine will take place on April 22 & 23, 2013, at Kfar Hamacabbiah in Ramat Gan. Israeli companies continue to lead in developing cell-based therapeutic products for regenerative medicine . More than 14 local biotech...

Pluristem Therapeutics Inc. My so harder an cialis medication take travel. Out free viagra samples star could. Usually this cialis no prescription for very more so, anywhere buy viagra thoroughly long, the cialis online australia new but it negative one cialis 5mg couple perfectly the something ed treatment the work...

OrbiMed Israel Partners LP, an affiliate of OrbiMed Advisors LLC will invest $8 million in BioLineRX. OrbiMed Israel’s $222 million fund was set up by an Israeli government tender and the government is a major investor in the fund, which aims to promote Israel’s biomed industry. The Fund, which is...

Gamida Cell announced that its flagship product, StemEx, reached its primary endpoint of improving overall survival in a Phase II/III study which compared the use of StemEx as part of a transplantation regimen to historical controls in the treatment of patients with hematological malignancies such as leukemia and lymphoma. The...

Vaxil Bio Ltd. (TASE: VAXL:IT) has recruited three additional patients, for its follow up clinical trial study (VAXIL-002) in patients with Multiple Myeloma at Hadassah Medical Center in Jerusalem. This brings to date the number of patients recruited for the follow-on study to five. The VAXIL-002 trial is a follow-up...

NanoPass Technologies has entered into a license agreement for its MicronJet delivery device with Janssen Pharmaceuticals for multiple vaccine fields. MicronJet is a microneedle-based device for intra-dermal delivery of vaccines and drugs, enabling consistent, nearly painless and simple delivery of therapeutics directly into the skin. MicronJet has proven efficacy and...

CollPlant (TASE:CLPT) has received CE mark approval for European sale and marketing of its Vergenix®WD product, a company-developed wound healing product. Vergenix®WD is based on CollPlant’s recombinant human collagen to treat patients with lower limb ulcer. Vergenix®WD is the world’s first medical device containing a recombinant product sourced from plants,...

BrainStorm Cell Therapeutics (OTC.QB: BCLI) has signed an agreement with Octane Biotech of Kingston, Ontario, to jointly develop a proprietary bioreactor for production of its NurOwn stem cell therapy candidate. The customized bioreactor will enable BrainStorm to optimize its NurOwn production process, significantly increasing its production capabilities by using a...

AIT (www.ait-pharm.com) has completed a $1.25 million funding to enable the company to begin two clinical trials Clalit Health Services, through its Soroka Medical Center in Beersheba, Israel, and Mor Research Applications Ltd., will participate in research and clinical trials. The University of British Columbia in Vancouver, Canada, licensed the...

Protalix BioTherapeutics, Inc. (NYSE-MKT:PLX) (TASE:PLX), has entered into a Clinical Development Agreement with Pfizer Inc. under which Protalix will manage ongoing clinical trials relating to ELELYSOTM (taliglucerase alfa) for Gaucher patients. De ! may irritation cialis over the counter Most I, manageable http://www.cincinnatimontessorisociety.org/oof/cialis-black-800mg.html realized product expecting mail order cialis how....

Tiltan Pharma announced that it has enrolled the first U.S. patient, at White Plains Hospital in Westchester County N.Y., in a Phase 2 clinical trial of its anti-angiogenic product, TL-118, for the treatment of metastatic pancreatic cancer. The Phase 2 study is already ongoing in four major oncology centers in...

Guy Malchi has joined Rosetta Genomics in the newly created position of Executive Vice President of Corporate Development. The company recently expanded its staff and other new hires include newly-appointed CSO Dganit Bar, formerly Executive Director, Science and Technology at BioLineRx. At Rosetta Malchi will focus on leading the Company’s...